Mirador Capital Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49M Buy
1,080,288
+7,052
+0.7% +$26.8K 0.55% 45
2026
Q1
$3.77M Buy
1,073,236
+38,692
+4% +$124K 0.53% 45
2025
Q4
$2.82M Buy
1,034,544
+519,519
+101% +$1.2M 0.39% 58
2025
Q3
$1.12M Buy
+515,025
New +$1.22M 0.16% 95
2022
Q4
Sell
-63,479
Closed -$608K 195
2022
Q3
$608K Sell
63,479
-1,211
-2% -$14K 0.15% 93
2022
Q2
$714K Buy
64,690
+21,585
+50% +$283K 0.17% 93
2022
Q1
$718K Buy
43,105
+3,039
+8% +$47K 0.15% 103
2021
Q4
$765K Buy
40,066
+14,772
+58% +$325K 0.16% 104
2021
Q3
$624K Buy
25,294
+1,036
+4% +$24.4K 0.14% 120
2021
Q2
$631K Buy
+24,258
New +$631K 0.14% 119

Other funds holding IOVA